Risk of Impaired Coagulation in Warfarin Patients Ascending to Altitude (>2400 m)

No abstract is available for this paper.

• Publication year

  2006

• Venue

  High Altitude Medicine & Biology

• Publication date

  2006-03-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1089/ham.2006.7.39PMID 16544965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m)

  2005cited by this paper
• Oral Anticoagulant Drug Interactions with Statins: Case Report of Fluvastatin and Review of the Literature

  2004cited by this paper
• Hypoxia and high altitude. The molecular response.

  2003cited by this paper
• Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia.

  2003cited by this paper
• Trends in Anticoagulation Management Across Community-Based Practices in the United States: The Anticoagulation Consortium to Improve Outcomes Nationally (ACTION) Study

  2003cited by this paper
• Hypoxia and High Altitude

  2003cited by this paper
• Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

  2003influential reference
• In vivo effect of 5‐ and 8‐methoxypsoralens and cimetidine on R,S‐warfarin metabolism in rat

  2002cited by this paper
• Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

  2002cited by this paper
• Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.

  2002cited by this paper
• Effect of Stress on International Normalized Ratio during Warfarin Therapy

  2002cited by this paper
• Stroke at High Altitude: Indian Experience

  2002cited by this paper
• High Altitude : An Exploration of Human Adaptation

  2001cited by this paper
• Human P450 metabolism of warfarin.

  1997cited by this paper
• Prevalence of stroke at high altitude (3380 m) in Cuzco, a town of Peru. A population-based study.

  1995cited by this paper
• A simple method for the derivation of the international normalized ratio for the reporting of prothrombin time results

  1995cited by this paper
• Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

  1995cited by this paper
• Interactions of Warfarin with Drugs and Food

  1994cited by this paper
• A population based study

  1993cited by this paper
• Blood.

  1989cited by this paper

• Review of Preexisting Medical Conditions in Persons Traveling to High Altitude, 2025.

  2025cites this paper
• Potential Association of Holidays on Internationalized Normalized Ratio in Warfarin-Users at a Multidisciplinary Clinic

  2023cites this paper
• Hemostatic Effects of Bio-Zeolite Gauze and QuikClot Combat Gauze on Major Bleeding in Rabbits Acutely Exposed to High Altitude

  2022cites this paper
• Time Course of Coagulo-Fibrinolytic Derangements During Acclimatization to High Altitude in Rabbits and a Preliminary Study on the Possible Mechanisms

  2022cites this paper
• Return to High Altitude After Recovery from Coronavirus Disease 2019

  2021cites this paper
• Working at high altitude

  2020cites this paper
• Prevalence of Anticoagulant Rodenticides in Ferruginous Hawk Nestlings and Evaluation of a Novel Method to Rapidly Assess Exposure

  2020cites this paper
• General Medical Considerations for the Wilderness Adventurer: Medical Conditions That May Worsen With or Present Challenges to Coping With Wilderness Exposure

  2015cites this paper
• Anticoagulation Considerations for Travel to High Altitude

  2015cites this paper
• General Medical Considerations for the Wilderness Adventurer: Medical Conditions That May Worsen With or Present Challenges to Coping With Wilderness Exposure.

  2015cites this paper
• Pre-existing cardiovascular conditions and high altitude travel. Consensus statement of the Medical Commission of the Union Internationale des Associations d'Alpinisme (UIAA MedCom) Travel Medicine and Infectious Disease.

  2014cites this paper
• High Altitude and Common Medical Conditions

  2014cites this paper
• Participation of Iatrogenically Coagulopathic Patients in Wilderness Activities

  2013cites this paper
• Haematological Changes at Altitude

  2011cites this paper
• Changes in Coagulation Factors at High Altitude: A Systematic Review

  2011influential citation
• Journeys to high altitude--risks and recommendations for travelers with preexisting medical conditions.

  2010cites this paper
• Travel and oral anticoagulation.

  2009cites this paper
• Atmospheric pressure changes and unexplained variability in INR measurements

  2009cites this paper
• Lung disease at high altitude

  2009cites this paper
• Accidente cerebrovascular en poblaciones situadas a grandes alturas: revisión y análisis de los factores de riesgo

  2008cites this paper
• Travel to high altitude with pre-existing lung disease

  2007cites this paper